中文 | English
Return
Total: 32 , 1/4
Show Home Prev Next End page: GO
Author:( Changping HU)

1.Obesity and adipose tissue remodeling

Yongyu YANG ; Changping HU

Chinese Pharmacological Bulletin 2016;(1):9-13

2.Mediation of neurotransmitters in the cardioprotection of ischemic preconditioning

Changping HU ; Yuanjian LI

Chinese Pharmacological Bulletin 1998;0(S1):-

3.Protective effects of shenmai injection on free radical-induced myocar dial injury in isolated rabbit hearts

Niansheng LI ; Changping HU

Chinese Journal of Clinical Pharmacology and Therapeutics 2002;0(06):-

4.Research progress in pharmacological actions of evodiamine and rutaecarpine

Changping HU ; Yuanjian LI ;

Chinese Pharmacological Bulletin 2003;0(10):-

5.Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-kB signaling pathway in rats

Jing YANG ; Yuanjian LI ; Changping HU

Journal of Central South University(Medical Sciences) 2011;36(10):972-978

6.To explore the experiment class reform in pharmacological course for 8-year medical students

Jun PENG ; Xiaoping CHEN ; Changping HU

Chinese Journal of Medical Education Research 2005;0(05):-

7.Experimental evaluation of the antihistamine effect of domestic azelastine hydrochloride

Xiaohong ZHANG ; Jinxiang WU ; Changping HU

Chinese Journal of Clinical Pharmacology and Therapeutics 2002;0(06):-

8.A new bioassay method to estimate the rat angiotensin Ⅰ converting engyme activity in vivo

Niansheng LI ; Changping HU ; Xiu CHEN ;

Chinese Pharmacological Bulletin 2003;0(07):-

9.Platelet-derived nitric oxide and cardiovscular diseases

Sujie JIA ; Changping HU ; Hanwu DENG ; Yuanjian LI

Chinese Pharmacological Bulletin 2003;0(11):-

10.Profilin-Ⅰand cardiovascular diseases

Jinfang CHENG ; Guohua NI ; Changping HU ; Tianlun YANG

Chinese Pharmacological Bulletin 1986;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 32 , 1/4 Show Home Prev Next End page: GO